v3.20.2
Condensed Consolidated Statements of Operations - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2020
Sep. 30, 2019
Sep. 30, 2020
Sep. 30, 2019
Revenues:        
Total revenues $ 18,385 $ 21,906 $ 48,023 $ 49,808
Costs and operating expenses:        
Cost of product revenue 3,642 5,067 7,882 12,230
Research and development 12,010 8,711 33,830 25,000
Selling, general and administrative 8,797 7,869 26,307 24,180
Total costs and operating expenses 24,449 21,647 68,019 61,410
Income (loss) from operations (6,064) 259 (19,996) (11,602)
Interest income 39 480 362 929
Other expenses, net (50) (403) (125) (615)
Income (loss) before income taxes (6,075) 336 (19,759) (11,288)
Provision for (benefit from) income taxes 19 (7) 331 12
Net income (loss) $ (6,094) $ 343 $ (20,090) $ (11,300)
Net income (loss) per share, basic (usd per share) $ (0.10) $ 0.01 $ (0.34) $ (0.20)
Net income (loss) per share, diluted (usd per share) $ (0.10) $ 0.01 $ (0.34) $ (0.20)
Weighted average common stock shares used in computing net income (loss) per share, basic (shares) 59,061 58,287 58,984 55,818
Weighted average common stock shares used in computing net income (loss) per share, diluted (shares) 59,061 61,412 58,984 55,818
Product Revenue [Member]        
Revenues:        
Total revenues $ 8,401 $ 10,351 $ 18,005 $ 24,588
Research and Development Revenue [Member]        
Revenues:        
Total revenues $ 9,984 $ 11,555 $ 30,018 $ 25,220

Source